Creatine Base Dianion Compound for Enhanced Solubility and Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing creatine compounds have low solubility and bioavailability, are unstable in acidic environments, and do not spray dry well due to hygroscopic nature, leading to potential conversion to creatinine and pH-related issues.

Innovation Solution

A creatine base dianion compound is formed by reacting creatine with an inorganic or organic dianion and a base, increasing solubility and stability, allowing for efficient spray drying and production of a low-moisture content powder suitable for supplements and foodstuffs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If traditional creatine compounds are used, then they can be supplied to the body, but they have low solubility and low bioavailability

Engineering Contradiction:
ImprovesolubilityVSAvoidbioavailability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent changes the chemical parameters of creatine by converting it from traditional salt forms (creatine monohydrate, creatine nitrate, creatine citrate) to a creatine base dianion compound. This chemical transformation fundamentally alters the solubility characteristics, enabling the compound to achieve high solubility in aqueous solutions while maintaining stability and bioavailability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite chemical structure by combining creatine with a base (such as sodium hydroxide, potassium hydroxide, or calcium hydroxide) and a dianion (such as sulfate, phosphate, or organic acid dianions). This composite approach produces a novel compound that integrates the beneficial properties of both components, achieving enhanced solubility without sacrificing stability.

Inventive Principle:
Principle #40Composite materials

2Ease of operation

If creatine is used in acidic environment, then it can be delivered to the stomach, but it converts to creatinine and loses effectiveness

Engineering Contradiction:
Improvedelivery to stomachVSAvoidstability in acidic environment
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent converts the harmful acidic environment of the stomach into a beneficial feature by designing a creatine base dianion compound that is specifically stable at low pH. The compound's unique structure allows it to resist degradation in acidic conditions, transforming the previously harmful stomach environment into a safe delivery pathway.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The invention changes the pH stability parameters of creatine by modifying its chemical structure to a base dianion form. This structural modification shifts the compound's stability profile, enabling it to maintain integrity across a broader pH range including the acidic conditions of the stomach, thereby preventing conversion to creatinine.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If creatine nitrate or creatine citrate is used, then solubility is improved, but they do not spray dry well due to hygroscopic nature

Engineering Contradiction:
ImprovesolubilityVSAvoidspray drying efficiency
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent extracts the hygroscopic property from the creatine compound by removing the problematic acid components (nitric acid, citric acid) that cause moisture absorption. The resulting creatine base dianion compound retains the desired solubility while eliminating the hygroscopic characteristic that interferes with spray drying, enabling efficient powder production.

Inventive Principle:
Principle #2Taking out (Extraction)

4Ease of manufacture

If traditional creatine compounds are used, then they can be formulated, but the finished pH is too low and could be harmful if ingested unbuffered

Engineering Contradiction:
Improveformulation flexibilityVSAvoidlow pH harm to consumer
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The creatine base dianion compound is self-buffering, meaning it inherently maintains a safe pH range without requiring additional buffering agents. The compound's chemical structure automatically resists extreme pH shifts, making it self-regulating and safe for ingestion without the need for external pH correction systems.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The creatine base dianion compound exhibits enhanced solubility and bioavailability, stability at low pH, and can be easily spray dried, preventing conversion to creatinine and ensuring safer ingestion.

Implementation Method 1

The resulting creatine base dianion compound has greatly increased solubility in aqueous solutions

Methodology Applied
Scientific EffectSolvation: Solvation

Implementation Method 2

it can more easily be spray dried, allowing for a production of a pure creatine compound with low moisture content

Methodology Applied
Scientific EffectEvaporation: Evaporation

Data Source

PatentUS20240075002A1Creatine composition and methods of using same
Publication Date: 2024.03.07 NANOCHEM SOLUTIONS INC

AI summary

A creatine composition comprising a base component, a dianion component, and a creatine component. In some exemplary embodiment, the base component and dianion component can at least be partially reacted before being added to the creating component. On a dry weight basis, the base component can comprise between about 7-20% of the composition by weight, the dianion component can comprise between about 35-50% of the composition by weight, and the creatine component can comprise between about 30-60% of the composition by weight. In embodiments where the base component and dianion component are first reacted to form a base dianion component, the base dianion component can comprise between about 40-65% of the composition by weight. The creatine component can comprise between about 35-60% of the composition by weight with the remainder of the composition being composed of deionized water (i.e., between about 0-10% of the composition by weight).